Investing Profile

Christopher R. Shepard

InvestorVC
Medical Scientist and Venture Partner, Apollo Health Ventures
apollo.vc/teamNew York, New York
Photo of Christopher R. Shepard, Venture Partner at Apollo Health Ventures
University of Sydney Network
19 CONNECTIONS
Carnegie Mellon University - Tepper School of Business Network
17 CONNECTIONS
Genentech Network
12 CONNECTIONS
Genentech Network
12 CONNECTIONS
cb
Apollo Health Ventures Venture Partner
$100K - $5.0M
$1.5M
Director Avogadro Development Corp2023 - Present
Board Trustee Prostate Cancer Research2021 - Present
Venture Partner Apollo Health Ventures2021 - Present
Chief Executive Officer, Director Avogadro Development Corp2019 - 2022
Director Carnot BioSciences, LLC2018 - 2022
Director Structured BioEquity SBE2017 - 2022
GM/Chief Executive, Director (US) Smartzyme Biopharma2018 - 2019
Chief Development Officer Smartzyme Biopharma2017 - 2018
Senior Vice President, Business and Portfolio Development Smartzyme Biopharma2017 - 2017
R&D Technical Evaluation (Translational - Phase 2) and Transactions Structured BioEquity SBE2013 - 2017
Principal and North America Leadership Team Deallus Consulting2012 - 2013
Business Unit Manager Deallus Consulting2012 - 2012
Senior Consultant Deallus Consulting2011 - 2012
Consultant Deallus Consulting2011 - 2011
Competitive Intelligence Genentech2009 - 2009
Scientist Massachusetts Institute of Technology2007 - 2008
Principal Investigator (Congressionally Directed Medical Programs for the Department of Defense) University of Pittsburgh School of Medicine2005 - 2007
Safety Assessment Pathology Genentech2002 - 2002
University of Pittsburgh School of Medicine PhD (Honors) Molecular and Cellular Pathology
Carnegie Mellon University - Tepper School of Business MBA Finance
Wake Forest University BSc Biology
University of Sydney Honors Work Statistical Physics